Merck's decision to withdraw Vioxx was driven by recent evidence that the drug's adverse side effects outweighed any potential benefits. 
 One can only speculate, but it may have less to do with side effects outweighing benefits than with legal liabilities outweighing profits. 
 Whatever the company's known, its decision to withdraw Vioxx should cast scrutiny on at least two problems inherent in the nation's system for assessing and monitoring drug safety. 
 Merck's decision to withdraw Vioxx was driven by recent evidence that the drug's adverse side effects outweighed any potential benefits. 
 One can only speculate,